
면역학 및 백신학은 면역 체계 기능의 메커니즘과 예방 및 치료 백신 개발을 다룹니다. 이 분야는 세포 및 분자 면역학, 항원 인식, 면역 기억, 숙주-병원체 상호작용을 통합하여 백신 제형, 보조제 및 전달 시스템을 설계하고 최적화합니다. 연구는 면역 조절, 면역병리학, 그리고 감염성 질환, 암, 자가면역 질환에 대한 백신 효능 향상 전략을 다룹니다. 지속적으로 업데이트되는 본 자료집은 면역학적 이해와 백신 혁신을 진전시키는 최신 동료 심사 연구 및 특허 기술을 제공합니다.
본 자료는 면역학 및 백신학 분야의 전 세계 영문 논문과 특허를 엄선하여 정리한 것으로, 다양한 온라인 과학 저널에 게재된 자료들을 항원, 항체, T세포, B세포, 면역원, 에피토프, 면역보조제, 면역화, 백신 효능, 면역 반응, 기억 세포, 사이토카인, 면역글로불린, 중화항체, 면역요법, 병원체 인식 수용체, 주요 조직적합성 복합체, 면역학, 백신, 면역 관용, 수지상 세포, 체액성 면역, 세포 매개 면역, 백신 제형, 생백신, 서브유닛 백신, 점막 면역, 면역 기억, 면역 체크포인트, 백신 보조제, 면역병리학 및 면역 조절 등의 주제로 분류하고 있습니다.
Methods of treating or preventing bone-related diseases or conditions
Patent published on the 2026-10-15 in WO under Ref WO2026214737 by ANGITIA INCORPORATED LTD [US] (Zovein Ann [us], Dent Ricardo [us], Dere Willard [us], Ke Hua Zhu [us], Zhang Yilong [us], Ke Juan [us], Yuan Baozhi [cn])
Abstract: It provides methods of treating or preventing bone-related disease or condition in an individual by administration of one or more agents that target both sclerostin and Dickkopf-related protein 1 (DKK-1). In some cases, the one or more agents is a bispecific antibody that binds to sclerostin and DKK-1.[...]
Our summary: This content discusses methods for treating or preventing bone-related diseases. It involves administering agents that target sclerostin and DKK-1. A bispecific antibody may be used to bind both targets.
bone diseases, sclerostin, DKK-1, bispecific antibody
Patent
Prediction of car neurotoxicity using network biosignatures
Patent published on the 2026-10-15 in WO under Ref WO2026218003 by SEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RESEARCH INST [US] (Smith Stephen Edward Paucha [us])
Abstract: Provided are methods and compositions related to toxicity associated with administration of cell therapy for the treatment of diseases or conditions, e.g., cancer, including methods for use in predicting and treating toxicity. In some embodiments, the toxicity is a neurotoxicity or cytokine release syndrome (CRS), such as severe neurotoxicity or severe CRS. The methods generally involve determining a biosignature comprising of a differential modulation of one or more protein-interactions in a CA[...]
Our summary: The content discusses methods for predicting car neurotoxicity using network biosignatures. It focuses on the differential modulation of protein interactions in CAR-T cells. Additionally, it includes strategies for treating or preventing severe neurotoxicity and cytokine release syndrome.
neurotoxicity, CAR-T cells, biosignature, cytokine release syndrome
Patent
Compositions and methods for enhancing the stability of a canine antibody
Patent published on the 2026-10-15 in WO under Ref WO2026217876 by ZOETIS SERVICES LLC [US] (Lightle Sandra Ann Marie [us], Sharp Courtney [us], Yuan Hua [us])
Abstract: The invention relates generally to compositions and methods for enhancing the stability of a canine antibody. Specifically, the invention relates to one or more mutations in a constant region, particularly a hinge region, of a canine antibody and uses thereof.[...]
Our summary: The invention focuses on compositions and methods to enhance the stability of canine antibodies. It specifically involves one or more mutations in the constant region, particularly the hinge region. The uses of these mutations are also discussed.
canine antibody, stability enhancement, mutations, hinge region
Patent
Novel heterobiaryl compound and composition for enhancing immune response comprising same as active ingredient
Patent published on the 2026-10-15 in WO under Ref WO2026216966 by CHUNG ANG UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION [KR] (Shin Sung Jae [kr], Kim Lee-han [kr], Kim Hongmin [kr], Jung Weonseok [kr], Kim Jae Hyun [kr], Cho Chan Jae [kr], Elvira Zaitseva [kr])
Abstract: The present invention relates to: a composition for enhancing an immune response, comprising a novel heterobiaryl compound; and a vaccine composition comprising same. The compound of the present invention can continuously enhance cellular and humoral immune responses by efficiently stimulating helper T cells. The compound of the present invention can, by itself, be used as a therapeutic composition for tuberculosis by stimulating an immune response alone in a subject infected with various pathog[...]
Our summary: The invention describes a novel heterobiaryl compound that enhances immune responses. It can be used as a therapeutic for tuberculosis and other infections. Additionally, it serves as an effective vaccine adjuvant to improve antigen-specific immune responses.
heterobiaryl compound, immune response, vaccine adjuvant, therapeutic composition
Patent
Memory devices with power gating control
Patent published on the 2026-10-15 in US under Ref US20260321303 by SAMSUNG ELECTRONICS CO LTD [KR] (Jeon Jiah [kr], Lee Minsu [kr])
Abstract: [0000] A memory device includes a memory cell array including one or more banks, a power gating switch disposed on a power path for transmitting a power supply voltage inside the memory device, a power gating controller configured to turn on or off a power gating operation of the power gating switch based on a temperature of the memory device and a frequency of an access to the memory device, and a control logic circuit configured to provide, to the power gating controller, temperature informati[...]
Our summary: A memory device features a memory cell array with a power gating switch. The power gating controller manages the switch based on temperature and access frequency. The switch toggles during access when power gating is on, remaining on when it is off.
power gating, memory device, temperature control, access frequency
Patent
Memory device and programming method of memory device
Patent published on the 2026-10-15 in US under Ref US20260321323 by SK HYNIX INC [KR] (Jo Eun Woo [kr])
Abstract: [0000] A memory device includes a plurality of memory cells and a peripheral circuit. The plurality of memory cells are connected to a plurality of word lines. The peripheral circuit performs, during a program period, a program operation on target memory cells connected to a selected word line among the plurality of word lines, applies, during a first intermediate period following the program period, a first intermediate voltage to the plurality of word lines, applies the first intermediate volt[...]
Our summary: A memory device consists of multiple memory cells and a peripheral circuit. The peripheral circuit executes a program operation on selected memory cells during a program period. It subsequently applies intermediate voltages and conducts a verification operation on the target memory cells.
memory device, memory cells, programming method, verification operation
Patent
Gene editing using large insertions
Published on 2026-09-17 by Alexandra Despang @NATURE
Abstract: Nature Biotechnology, Published online: 17 September 2026; doi:10.1038/s41587-026-03319-6While technologies for smaller gene edits, such as base editing, have already entered clinical trials, larger gene cargoes face different challenges, including low editing efficiencies, delivery vehicle size constraints, and possible immunogenicity. Programmable genome engineering systems using recombinases; transposases, including CRISPR-associated transposases (CASTs); genome writing systems; and retrotran[...]
Our summary: The article discusses the challenges of gene editing with large insertions, highlighting issues like low editing efficiencies and delivery constraints. It reviews various programmable genome engineering systems, including recombinases and CRISPR-associated transposases. Experts share insights on strategies to enhance these technologies for therapeutic applications.
gene editing, large insertions, genome engineering, CRISPR
Publication
pH-responsive amphiphilic peptide nanofibers facilitate endosomal escape for cytosolic protein delivery
Published on 2026-06-16 by Tomonori Waku, Chikae Sakata, Tomoki Matsuda, Kotone Minato, Hiroyasu Takemoto, Kazuya Matsuo, Akio Kobori @NATURE
Abstract: Polymer Journal, Published online: 16 June 2026; doi:10.1038/s41428-026-01212-2We developed pH-responsive amphiphilic peptide nanofibers (NFs) that may facilitate cytosolic protein delivery by selectively destabilizing endosomal membranes. The NFs were based on β-sheet-forming peptides conjugated with oligoglutamic acid segments, and the number of Glu residues was varied to optimize pH-responsive activity. Optimized NFs showed strong membrane-destabilizing activity at mildly acidic pH but remai[...]
Our summary: The study presents pH-responsive amphiphilic peptide nanofibers designed to enhance cytosolic protein delivery. These nanofibers destabilize endosomal membranes at mildly acidic pH while remaining stable at neutral pH. When tested with ovalbumin in dendritic cells, they improved MHC class I presentation of the OVA-derived epitope.
pH-responsive, amphiphilic, peptide nanofibers, cytosolic delivery
Publication

















